Victory Capital Management Inc Heron Therapeutics, Inc. Transaction History

Victory Capital Management Inc

$99 Billion
Q3 2024

A detailed history of Victory Capital Management Inc transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 18,282 shares of HRTX stock, worth $21,207. This represents 0.0% of its overall portfolio holdings.

Number of Shares

18,282

Previous 18,012 1.5%

Holding current value

$21,207

Previous $63,000 42.86%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$1.73 - $3.67 $467 - $990	270 Added 1.5%	18,282 $36,000
Q2 2024 Aug 05, 2024	SELL	$2.32 - $3.86 $1,739 - $2,895	-750 Reduced 4.0%	18,012 $63,000
Q1 2024 May 03, 2024	SELL	$1.71 - $3.06 $1,995 - $3,571	-1,167 Reduced 5.86%	18,762 $51,000
Q4 2023 Feb 05, 2024	BUY	$0.54 - $1.82 $2,493 - $8,402	4,617 Added 30.15%	19,929 $33,000
Q3 2023 Nov 06, 2023	BUY	$0.97 - $1.8 $2,351 - $4,363	2,424 Added 18.81%	15,312 $15,000
Q2 2023 Jul 27, 2023	SELL	$1.11 - $2.88 $331 - $861	-299 Reduced 2.27%	12,888 $14,000
Q1 2023 May 02, 2023	SELL	$1.51 - $3.25 $258 - $555	-171 Reduced 1.28%	13,187 $19,000
Q4 2022 Feb 09, 2023	BUY	$2.25 - $4.67 $3,836 - $7,962	1,705 Added 14.63%	13,358 $33,000
Q3 2022 Nov 02, 2022	SELL	$2.66 - $5.37 $3,088 - $6,234	-1,161 Reduced 9.06%	11,653 $49,000
Q2 2022 Aug 01, 2022	SELL	$2.3 - $6.29 $101 - $276	-44 Reduced 0.34%	12,814 $36,000
Q1 2022 May 04, 2022	SELL	$4.63 - $9.94 $5,005 - $10,745	-1,081 Reduced 7.76%	12,858 $58,000
Q4 2021 Feb 07, 2022	SELL	$8.35 - $12.6 $3,590 - $5,418	-430 Reduced 2.99%	13,939 $127,000
Q3 2021 Nov 02, 2021	SELL	$10.13 - $15.0 $7,232 - $10,710	-714 Reduced 4.73%	14,369 $154,000
Q2 2021 Aug 03, 2021	BUY	$13.27 - $18.48 $14,928 - $20,790	1,125 Added 8.06%	15,083 $234,000
Q1 2021 May 04, 2021	SELL	$14.49 - $20.72 $5,057 - $7,231	-349 Reduced 2.44%	13,958 $226,000
Q4 2020 Feb 01, 2021	BUY	$14.61 - $22.14 $10,665 - $16,162	730 Added 5.38%	14,307 $303,000
Q3 2020 Nov 09, 2020	BUY	$13.67 - $17.77 $185,597 - $241,263	13,577 New	13,577 $201,000

Others Institutions Holding HRTX

# of Institutions

180

Shares Held

121M

Call Options Held

80.4K

Put Options Held

94.9K

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $138M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account

Victory Capital Management Inc Heron Therapeutics, Inc. Transaction History